Nonalcoholic fatty liver disease (NAFLD) is a systemic disorder with a complex multifactorial
pathogenesis and heterogenous clinical manifestations. NAFLD, once believed to be an …

Liver disease is the spectrum of liver damage ranging from simple steatosis called as
nonalcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC). Clinically …

The liver is both an immunologically complex and a privileged organ. The innate immune
system is a central player, in which the complement system emerges as a pivotal part of liver …

The prevalence of hepatocellular carcinoma (HCC) is increasing worldwide, whereas that of
most other cancers is decreasing. Non-alcoholic fatty liver disease (NAFLD), which has …

Hepatocellular carcinoma (HCC) is the sixth most common cancer in world and third largest
cause of cancer-related deaths. The last few decades have witnessed the emergence of non …

The proportion of obese or diabetic population has been anticipated to increase in the
upcoming decades, which rises the prevalence of nonalcoholic fatty liver disease (NAFLD) …

Obesity, type 2 diabetes mellitus (T2 DM) and aging are associated with pancreatic cancer
risk, but the mechanisms of pancreatic cancer development caused by these factors are not …

Purpose This study aims to examine the burden of primary liver cancer in 185 countries in
2018. Methods The estimates of incidence, mortality and prevalence of primary liver cancer …

Nonalcoholic fatty liver disease (NAFLD) includes nonalcoholic fatty liver (NAFL),
nonalcoholic steato hepatitis (NASH) and NASH cirrhosis. NAFLD is the leading cause of …

More than 80% of global hepatocellular carcinoma (HCC) patients are estimated to occur in
sub-Saharan Africa (SSA) and Eastern Asia. The most common risk factor of HCC in SSA is …